does borderline personality disorder get worse with age
Abstract
Purpose of Review
To provide an update of a life span perspective on deadline personality disorder (BPD). We accost the life span class of BPD, and talk over possible implications for assessment, treatment, and research.
Recent Findings
BPD beginning manifests itself in adolescence and can be distinguished reliably from normal adolescent development. The course of BPD from boyhood to late life is characterized by a symptomatic switch from affective dysregulation, impulsivity, and suicidality to maladaptive interpersonal operation and indelible functional impairments, with subsequent remission and relapse. Dimensional models of BPD appear more historic period neutral and more useful across the unabridged life bridge. In that location is a need for age-specific interventions beyond the life bridge.
Summary
BPD symptoms and impairments tend to wax and wane from adolescence upwardly to old historic period, and presentation depends on contextual factors. Our agreement of the onset and early course of BPD is growing, but knowledge of BPD in tardily life is limited. Although the categorical criteria of DSM allow for reliable diagnosis of BPD in adolescence, dimensional models announced both more age neutral, and useful up to late life. To business relationship for the fluctuating expression of BPD, and to guide evolution and selection of treatment beyond the life span, a clinical staging model for BPD holds hope.
Introduction
The term borderline was outset coined by Adolph Stern in 1938 when he identified a "border line group of patients" who "fit frankly neither into the psychotic nor into the psychoneurotic group, and are extremely difficult to handle by whatever psychotherapeutic method" [one]. The acceptance of borderline personality disorder (BPD) every bit a mental disorder in the Diagnostic and Statistical Transmission of Mental Disorders (DSM) third edition in 1980 [two] has stimulated both clinical and scientific attention. BPD is characterized by impulsivity, self-impairment, suicidality, and emotional and interpersonal instability. DSM-5 [3], like DSM-IV [4], allows diagnosing BPD under the historic period of 18, if the symptoms are pervasive, persistent, not limited to a particular developmental stage or another mental disorder, and if the symptoms have been present for at least 1 twelvemonth.
The categorical DSM concept of BPD, and of personality disorders in general, has been criticized because of its heterogeneity, diagnostic overlap with other disorders, arbitrary threshold, depression reliability, and poor empirical base [v]. Factor analytic studies establish support for 1 general factor of personality pathology underlying the nine criteria of BPD [vi, 7•]. Moreover, BPD presents with many comorbid disorders [8]. Because of these limitations, a growing number of studies focuses on dimensional models of personality disorders, such as the Alternative Model of Personality Disorders (AMPD) in the DSM-5 and the new personality disorder concept of the International Classifications of Diseases 11th Edition (ICD-xi) [9]. Both models combine a severity dimension of personality pathology and a clarification of five personality trait domains. In the DSM-5 AMPD, BPD is defined past negative affectivity, disinhibition and psychoticism, and several studies take indicated full general support for these traits proposed for BPD [ten,11,12]. Interestingly, ICD-11 does not retain any specific personality type with the exception of an optional specifier for "borderline blueprint", operationalized as requiring at to the lowest degree five out of 9 criteria adapted from the DSM-5 criteria for BPD [nine].
Until effectually 1990, therapeutic nihilism prevailed concerning the treatment options of BPD [13]. Since then, beneficial effects take been demonstrated for 4 comprehensive treatments: dialectical behavior therapy (DBT), mentalization-based treatment (MBT), transference-focused psychotherapy (TFP), and schema therapy [14, 15]. However, treatment studies have mainly been conducted in adults betwixt the ages of 25 and 40, and effects remain modest and unstable at follow-up [fourteen, 15].
Recently, a life bridge perspective on BPD has been introduced, stressing a lifelong vulnerability of impairments in personality functioning, including poor mentalizing and dumb social cognition, along with persisting maladaptive traits like impulsivity, emotional lability, and separation insecurity [16•]. Traits and impairments are supposed to underpin the phenomenological presentation, which may wax and wane throughout the life bridge, depending on the complex and changing nature-nurture interactions from early babyhood onwards [16•].
This review provides an update of recent studies and viewpoints on a life span perspective on BPD, and discusses possible implications for assessment, treatment, and research. A systematic literature search was conducted for articles published between January 2022 and Jan 2022 using the MEDLINE and PsycINFO databases. The keyword "Borderline Personality Disorder" combined with "life span" or its synonyms ("clinical class" and "class") yielded 145 articles. We included 33 relevant articles (clinical trials or reviews) on life bridge perspective, risk factors, assessment, treatment, and comorbidity of BPD. We excluded manufactures that did not contribute to a life bridge perspective or did non primarily investigate BPD, were case reports, or were written in languages other than English.
Waxing and Waning Course of BPD from Childhood to Old Age
Babyhood and Adolescence
Until the past decade, the vast majority of our knowledge of BPD concerned diagnosis and handling of female patients in early adulthood. Since and so, BPD has also been studied more extensively in adolescents. This research points out that BPD typically commencement manifests itself in adolescence, and that adolescent BPD symptoms tin can exist distinguished reliably from normative adolescent evolution [17]. Moreover, adolescence tin be considered a particular sensitive catamenia for BPD pathology to sally [7•]. 2 large longitudinal studies into the trajectory of BPD from childhood into immature adulthood have shown that BPD pathology has its onset in the beginning of adolescence [18, 19]. Over 30% of adult BPD patients reported retrospectively that the onset of self-injurious behavior was earlier the age of 13, while in another 30%, this behavior started between the ages of 13 and 17 [20]. From childhood to late boyhood, vulnerable children destabilize considering of a wide range of risk factors [21]. These include the post-obit: low social economic status, stressful life events, family unit adversity, maternal psychopathology, cold, hostile or harsh parenting, exposure to concrete or sexual abuse or neglect, low IQ, high levels of negative affectivity and impulsivity, and both internalizing (low, feet, dissociation) and externalizing (attention-deficit hyperactivity disorder, oppositional defiant disorder, conduct disorder, substance use) psychopathology in childhood [21]. These hazard factors predict non only BPD, but a wide range of mental disorders. Prognostic factors that are specifically associated with a BPD development in children have not yet been identified [7•, 21].
In adolescence, those individuals who practise develop BPD can reliably be distinguished from those with a healthy development [22, 23]. Impulsivity, identity bug and affective instability diminish in the course of boyhood in healthy youngsters, whereas these symptoms increase over time in BPD adolescents [23,24,25]. The differentiation between healthy development and BPD becomes more pronounced throughout adolescence [26].
Several studies have plant prevalence rates of BPD in adolescents that are like to those in adult populations, 1–3% in community-dwelling samples, 33–49% in clinical samples and 11% in outpatient samples [27,28,29]. This growing empirical evidence supports that DSM-v, ICD-xi, and several national treatment guidelines allow the diagnosis of BPD in boyhood [30, 31].
In sum, BPD first emerges in boyhood and symptoms mainly include impulsive behaviors and affective instability.
Adulthood
The class of BPD from adolescence to adulthood is characterized by a symptomatic switch from predominantly symptoms of affective dysregulation, impulsivity, and suicidality to maladaptive interpersonal performance and enduring functional impairments, with subsequent periods of remission and relapse of the full categorical BPD diagnosis, i.east., coming together the threshold of at least v out of 9 DSM-criteria for BPD [16•, 32, 33]. Longitudinal studies show a general decrease of total BPD diagnoses from young to middle adulthood [34, 35]. However, remission of the categorical BPD diagnosis is commonly followed by relapse, and almost half of BPD patients never recover fully, both socially and vocationally [35, 36]. The class of core features of BPD, as assessed with retrospective questionnaires, persists throughout machismo, such equally melancholia symptoms (chronic dysphoria, anger, and feelings of emptiness), and interpersonal symptoms related to fears of abandonment, whereas impulsivity decreases during adulthood [35,36,37]. A recent cross-exclusive e-diary written report in everyday life showed higher affective instability prospectively between patients with BPD and good for you controls, ranging from fourteen to 53 years of age, and also showed that melancholia instability declined with greater age in BPD [38]. Generally, the behavioral symptoms of personality disorders are less stable than the personality traits associated with BPD over time [39, 40••]. Although self-injurious and suicidal beliefs decreases, gamble of suicide remains as loftier as 10% over a 27-year course [37, 41]. Symptoms of BPD wax and wane over time, and the acute symptoms (e.grand., suicidality, self-harm) change more than quickly and more readily than the temperamental symptoms (e.g., dysphoria, feelings of emptiness, and fearfulness of abandonment) [40••].
BPD in young adulthood predicts a host of negative outcomes across the life bridge, including mood, feet, eating and substance use disorders, increased risk for physical illnesses and medical care, reduced quality of life, and reduced life expectancy [39, 42,43,44,45]. Equally a consequence, many BPD patients never manage to fully participate in society [34, 46].
Research on predictors of outcome of BPD, based upon the naturalistic form from boyhood into middle machismo, has identified both positive and negative prognostic factors [40••, 46]. Predictors of skillful outcomes seem to be related mostly to personal capacity and competence, such as having a higher IQ, prior good full-time vocational functioning, higher levels of extraversion, college levels of conjuration, and lower levels of neuroticism. Predictors of poor outcomes are related to greater severity and chronicity of the disorder, higher degrees of comorbidity, and a history of childhood arduousness. Non-recovered patients, which brand up nearly 40%, experience higher rates of vocational damage, disability, physical morbidity, and bloodshed than recovered patients [46].
Late Life
Almost longitudinal studies of BPD take not included people over the historic period of 50; because of this, our agreement of the course of BPD into late life is limited [16•]. Cross-sectional studies suggest a further pass up in the prevalence of BPD from center adulthood to old historic period [47, 48••]. The only ongoing longitudinal study into the prevalence and impact of personality pathology in subsequently life, the SPAN study (St. Louis Personality and Aging Network), included patients between the ages of 55 and 64 and found a prevalence rate for BPD of 0.4%, and 0.6% if people with one benchmark short for the full DSM BPD-diagnosis were included [49]. Different explanations can be pointed out for this decline in the prevalence of BPD. BPD patients, especially those that do not recover, are at elevated gamble of premature decease, due to suicide or other causes [50], related to an unhealthy and sometimes reckless lifestyle [51]. Furthermore, there are age differences in the expression of BPD symptoms. In a report amid 1447 patients, anile 15–82 years, a significant pass up was found in the externalizing aspects of BPD symptoms to the historic period of 50, such as impulsivity, rule breaking, and emotional turmoil, whereas abandonment fears, selfishness, lack of empathy, and manipulation remained the same [52]. In the SPAN study, iii symptoms of BPD predicted interpersonal stressful life events: unstable interpersonal relationships, impulsivity, and chronic feelings of emptiness [53]. Interestingly, although impulsivity decreased with age in BPD, it continued to result in these negative consequences. BPD has also been found to predict arthritis and heart disease, in which obesity accounts for some of the variance in this human relationship [44, 54].
Recent large-scale IRT analyses on data of the National Epidemiologic Survey on Alcohol and Related Weather (NESARC) amidst more than 34,000 customs-dwelling people, aged betwixt 19 and 90 years, examined age differences in the likelihood of endorsing DSM-symptoms of BPD, when equating for levels of BPD symptom severity [48••]. Older people were consistently less likely to written report suicidal/cocky-harm behavior than younger respondents and unstable/intense interpersonal relationships appeared to discriminate BPD severity better in the youngest age group compared to the oldest age group, with equivalent levels of BPD severity. Information technology was further found that the nine DSM BPD-criteria provide substantially less information (fourteen.7%) in older than in younger adults. Overall, these findings indicate substantial age-related differences in BPD symptom expression.
Instance studies and clinical experience advise that features of BPD can be exacerbated in former historic period due to contextual changes, even causing a growing prevalence of BPD in residential care and psychiatric facilities for the elderly [55,56,57,58]. Poor interpersonal operation has caused many sometime BPD patients to be estranged from their family unit and former friends, and when they get dependent for intendance, this might re-trigger insecure zipper style problems and fears of abandonment [55]. BPD symptoms, together with trait neuroticism, appeared unique predictors of greater suicidal ideation in older adults, over other personality disorders and normal-range personality traits [59].
In an international Delphi study, experts in personality disorders in older adults reached consensus on the concept of "belatedly-onset personality disorder": a personality disorder that presents for the first fourth dimension in old age equally life events contribute to the expression of tardily-onset PD, with the major ones existence death of a spouse or partner and transition to a nursing home or assisted-living facility [sixty]. This concept of a personality disorder emerging in late life is consistent with the ICD-11; while ICD-x states that personality disorders tend to be stable over time, the ICD-11 guideline explicitly states that personality disorders are only "relatively" stable after young machismo, and may modify such that a person with a personality disorder in young adulthood no longer meets full criteria by heart age [ix, 61]. In some cases, a person who earlier did not have a diagnosable personality disorder, may develop one afterwards in life. Sometimes, emergence of personality disorder in older adults may exist related to the loss of social supports that had previously helped to compensate for personality disturbance. Triggers for tardily-onset BPD could be the loss of loved-ones, which might retrigger fears of abandonment.
In sum, a life span perspective on BPD could take important implications. Instead of beingness a fixed ready of BPD symptoms, that is invariant throughout the life span, BPD features are dynamic in nature and their expression depends on contextual and developmental factors from childhood up to old age [56]. Almost BPD patients demonstrate a waxing and waning profile of harm throughout adult life with periods of remission and relapse, while some bear witness stable remission [40••]. This fluctuating nature of BPD should have major touch on our assessment and treatment of BPD throughout the life span.
Cess Implications of a Life Span Perspective
A life span perspective has two major implications for assessment of BPD. First, as the current categorical BPD diagnosis has appeared to be non age-neutral, peculiarly in sometime historic period because of the changing expression of BPD symptoms [48••], it could exist advocated to develop age-specific cess instruments, or instruments that are age-neutral. For example, an historic period-specific BPD screening musical instrument could be adult for the detection of BPD in older adults. The conceptualization of BPD in the AMPD in DSM-v, with levels of personality performance (criterion A) and maladaptive trait dimensions (criterion B), has been studied for its age-neutrality in community-habitation older adults, anile 61 and over [62]. The Curt Form of the Severity Indices of Personality Problems (SIPP-SF), a questionnaire which can be used to assess criterion A, was establish to be relatively age-neutral, as merely half dozen% of the items performed differently for younger and older adults [62]. Of the Personality Inventory for DSM-5 (PID-5), which is designed to assess criterion B, merely 16% of the 25 PID-five facet-level scales showed potential age bias [63]. The cursory version of this instrument, the PID-5-BF, appeared to show more age bias, equally 25% of the five trait dimensions functioned differently in older adults [62]. Overall, these findings bespeak that the AMPD functions similarly in older and younger adults, and is to exist preferred over the electric current categorical model. Particularly criterion A seems to be more historic period-neutral than criterion B.
The 2d implication of a life bridge perspective on BPD would be to develop a model that accounts for the development and peradventure chronic class of BPD across the life bridge. Therefore, some authors take suggested a clinical staging model for BPD [56, 64••]. Staging models of diseases originated in oncology and have been adult for mental disorders, for case for psychosis [65]. The outset clinical staging model for BPD was proposed for guiding early intervention in adolescence with BPD and comorbid mood disorders [64••], and was recently elaborated to appraise the severity of BPD impairment throughout the life span [56]. Clinical staging offers a description of the progression of a disorder along a continuum of disorder progression, in which progression is typically specified into five stages, from a pre-morbid stage to an end or chronic phase [66]. Clinical staging is useful for personalized pick of advisable interventions that friction match with the stage of disease an individual is in. Although a typical staging profile of BPD starts in a premorbid stage in childhood and develops into a subclinical phase in early adolescence and to a get-go episode of full BPD in middle or late adolescence, followed past remission and relapse from heart to late machismo, other trajectories are possible. For example, in the case of late onset BPD, people might live for many decades in a subclinical stage, and only develop significant issues, and meet total BPD criteria subsequently in life. Another stage trajectory might be that BPD wanes into fractional remission in middle adulthood, because of a relationship with a stable spouse, merely re-emerges in quondam historic period, due to the destabilizing effects of bereavement, or physical decline and admittance to a nursing domicile. Clinical staging might shift attending towards the degree in which borderline impairment has progressed and its affect upon age-specific developmental tasks across the life span [56]. Adopting a clinical staging model across the life bridge could be helpful to pattern interventions tailored to the phase of BPD.
Handling Implications of a Life Bridge Perspective
As said, almost of our noesis of psychotherapeutic treatment of BPD comes from studies conducted in adults between the ages of 25 and 40 years, and these treatment models are focused on the acute episodes of the disorder. Typically, specialized treatments are offered rather late in the grade of BPD, tend to be costly and lengthy, and available merely to a subgroup of BPD patients who do seek help and manage to attend to the treatment setting [67]. Furthermore, every bit most existing treatments for BPD focus largely on the acute symptoms of self-impairment and impulsivity, it might be fruitful to develop interventions that target underlying impairments, such equally the affective symptoms, and improve social and vocational performance, as they have been associated with recovery [forty••, 46].
A life bridge perspective, adopting a clinical staging model, could be specially helpful to pattern interventions tailored to the stage of BPD. The earliest intervention is prevention of the onset of BPD by wide prevention programs. An example is preventing the transgenerational transmission of BPD, like mentalization-based treatment for parents (MBT-P) [68]. Early on treatment programs target adolescents with emerging signs of BPD, such as Helping Young People Early-Cerebral Analytic Therapy (HYPE-Cat) [69]. Specific treatments have been adult for adolescents, such every bit DBT for adolescents (DBT-A) [70], and MBT for adolescents (MBT-A) [71]. Early intervention programs might likewise be developed for people with subthreshold BPD in late adulthood to forbid emerging late onset BPD, and for older adults with a get-go episode of acute BPD. Such treatment programs could focus on helping the older patient to adapt to age-specific stressors, similar the death of a spouse or coping with becoming dependent for care. Adaptations of standard treatment programs, like MBT, DBT, TFP, and schema therapy, are needed for BPD in late life, and the first trial of schema therapy for BPD in older adults is currently existence conducted [72]. Finally, specific treatment programs are needed for the delicate and "old-onetime" BPD patients, which could be focused on staff understanding and behavioral management in care settings.
Research into the efficacy and tolerability of symptom-based pharmacotherapy for BPD [73, 74] consists of relatively few trials, and is based on findings in adults up to 50 years of age, and the quality of these studies is mostly low [74]. There is a lack of research on pharmacotherapy for BPD in adolescence and in older adults. Especially in older adults, polypharmacy and irresolute pharmacodynamics and pharmacokinetics are complicating factors in pharmacotherapy in BPD, which can lead to side effects and interactions [75].
Implications for Inquiry
A life span perspective on BPD also helps defining new enquiry objectives. One such goal would be to stop examining distal take chances factors that are indicative for later full general psychopathology and shed light on which precursors in childhood and boyhood are specific for BPD [vii•], and what personal and contextual characteristics determine a 'high-risk' profile for chronic BPD. In doing and so, we would be able to place which children are at ultrahigh take chances for the development of BPD.
Another major research implication of a life bridge perspective on BPD is to investigate whether the new dimensional models of DSM and ICD-11 indeed are capable of capturing the irresolute expression of BPD across the entire life span [16•]. Cess of the AMPD with the SIPP-Sf and the PID-five appears to be relatively age-neutral, except for the brief version of the PID-5. Therefore, the PID-BF should be examined in other populations, especially in clinical populations.
Furthermore, enquiry could focus on the applicability of a life span clinical staging model for BPD, and on the added value of this model for selecting more appropriate interventions. The focus in handling studies has been for likewise long on comparison specialized psychotherapies in developed BPD patients, just should turn to examining generic working mechanisms. Furthermore, at that place is a demand to arrange specific treatment approaches throughout the life span, equally they were designed for (young) adults and do not match with the needs of adolescents and older adults. Early intervention programs demand to be developed and assessed for their efficacy across the entire life span. In the long run, early detection and intervention may prevent to a big extent that BPD evolves to a chronic phase in many cases, only for at present nosotros demand to develop effective treatments for BPD in late life. This involves the accommodation of integrative treatments for older adults, but likewise behavioral management programs for one-time BPD patients in residential and home care.
Conclusions
In that location is accumulating knowledge on the onset and grade of BPD across the life span. Our understanding of the onset and early on form of BPD is growing, but knowledge of BPD in late life is still very limited. BPD offset manifests itself in boyhood, and can be distinguished reliably from normative adolescent evolution. BPD symptoms and impairments continue to wax and wane up to old age, and their expression depends on contextual and developmental factors. The course of BPD from adolescence to adulthood is characterized past a symptomatic switch from predominantly symptoms of melancholia instability and impulsivity to maladaptive interpersonal functioning and enduring functional impairments, with subsequent periods of remission and relapse of the full chiselled BPD diagnosis. Although the categorical criteria of DSM let for reliable diagnosis of BPD in adolescence, dimensional models announced both more age neutral, and especially more than useful in subsequently life. To guide early on intervention and meliorate treatment selection across the life span a clinical staging model for BPD holds promise.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.
Stern A. Psychoanalytic investigation of and therapy in the border line group of neuroses. Psychoanal Q. 1938;7:467–89.
- ii.
American Psychiatric Association. Diagnostical and statistical manual of mental disorders. 3rd ed. Washington: American Psychiatric Publishing; 1980.
- three.
American Psychiatric Clan. Diagnostical and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Publishing; 2022.
- iv.
American Psychiatric Association. Diagnostical and statistical manual of mental disorders. 4th ed text rev. Washington: American Psychiatric Publishing; 2000.
- 5.
Mulder RT, Newton-Howes G, Crawford MJ, Tyrer PJ. The central domains of personality pathology in psychiatric patients. J Personal Disord. 2022;25:364–77. https://doi.org/x.1521/pedi.2011.25.3.364.
- half dozen.
Sharp C, Wright AG, Fowler JC, Frueh BC, Allen JG, Oldham J, et al. The structure of personality pathology: both general ('g') and specific ('s') factors? J Abnorm Psychol. 2022;124:387–98. https://doi.org/10.1037/abn0000033.
- 7.
• Sharp C. Electric current trends in BPD research equally indicative of a broader sea-alter in psychiatric nosology. Personality Disord. 2022;7:334–43. https://doi.org/ten.1037/per0000199 Reviews current trends in BPD enquiry.
- 8.
Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Axis I comorbidity in patients with deadline personality disorder: half-dozen-year follow-up and prediction of time to remission. Am J Psychiatry. 2004;161:2108–14. https://doi.org/ten.1176/appi.ajp.161.11.2108.
- nine.
World Health Organization. International statistical classification of diseases and related health bug. 11th rev. Geneva: World Health System; 2022.
- 10.
Watters CA, Bagby RM, Sellbom M. Meta-analysis to derive an empirically based set of personality facet criteria for the culling DSM-5 model for personality disorders. Personality Disord. 2022;10:97–104. https://doi.org/10.1037/per0000307.
- 11.
Bach B, Sellbom Yard. Continuity between DSM-five categorical criteria and traits criteria for deadline personality disorder. Can J Psychiatr. 2022;61:489–94. https://doi.org/x.1177/0706743716640756.
- 12.
Fowler JC, Madan A, Allen JG, Patriquin M, Sharp C, Oldham JM, et al. Clinical utility of the DSM-5 alternative model for deadline personality disorder: differential diagnostic accuracy of the BFI, SCID-II-PQ, and PID-5. Compr Psychiatry. 2022;lxxx:97–103. https://doi.org/10.1016/j.comppsych.2017.09.003.
- 13.
Livesley WJ, Dimaggio G, Clarkin JF. Why integrated treatment? General principles of therapeutic change. In: Livesley WJ, Dimaggio Grand, Clarkin JF, editors. Integrated treatment for personality disorder: a modular arroyo. New York: Guilford Press; 2022.
- fourteen.
Stoffers JM, Völlm BA, Rücker G, Timmer A, Huband North, Lieb Yard. Psychological therapies for people with borderline personality disorder. Cochrane Database Syst Rev. 2022;8. https://doi.org/ten.1002/14651858.CD005652.pub2.
- 15.
Cristea IA, Gentili C, Cotet CD, Palomba D, Barbui C, Cuijpers P. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiat. 2022;74:319–28. https://doi.org/ten.1001/jamapsychiatry.2016.4287.
- sixteen.
• Newton-Howes G, Clark LA, Chanen A. Personality disorder across the life class. Lancet. 2022;385:727–34. https://doi.org/10.1016/S0140-6736(14)61283-6 This commodity reviews a broader life course perspective for all personality disorders.
- 17.
Chanen AM. Borderline personality disorder in young people: are nosotros in that location yet? J Clin Psychol. 2022;71:778–91. https://doi.org/x.1002/jclp.22205.
- 18.
Cohen P, Crawford TN, Johnson JG, Kasen Southward. The children in the customs study of developmental course of personality disorder. J Personal Disord. 2005;nineteen:466–86. https://doi.org/10.1521/pedi.2005.19.5.466.
- 19.
Stepp SD, Pilkonis PA, Hipwell AE, Loeber R, Stouthamer-Loeber M. Stability of borderline personality disorder features in girls. J Personal Disord. 2022;24:460–72. https://doi.org/x.1521/pedi.2010.24.4.460.
- xx.
Zanarini MC, Frankenburg FR, Ridolfi ME, Jager-Hyman Due south, Hennen J, Gunderson J. Reported childhood onset of cocky-mutilation amid borderline patients. J Personal Disord. 2006;20:nine–15. https://doi.org/10.1521/pedi.2006.20.1.9.
- 21.
Stepp SD, Lazarus SA, Byrd AL. A systematic review of risk factors prospectively associated with borderline personality disorder: taking stock and moving forward. Personal Disord Theory Res Treat. 2022;7:316–23. https://doi.org/x.1037/per0000186.
- 22.
Nakar O, Brunner R, Schilling O, Chanen A, Fischer Yard, Parzer P, et al. Developmental trajectories of self-injurious behavior, suicidal beliefs and substance misuse and their clan with adolescent borderline personality pathology. J Touch Disord. 2022;197:231–8. https://doi.org/10.1016/j.jad.2016.03.029.
- 23.
De Fruyt F, De Clercq B. Antecedents of personality disorder in childhood and adolescence: toward an integrative developmental model. Annu Rev Clin Psychol. 2022;10:449–547. https://doi.org/10.1146/annurev-clinpsy-032813-153634.
- 24.
Chanen AM, Jackson HJ, McGorry PD, Allot KA, Clarkson V, Yuen HP. Two-twelvemonth stability of personality disorder in older adolescent outpatients. J Personal Disord. 2004;18:526–41. https://doi.org/ten.1521/pedi.xviii.6.526.54798.
- 25.
Ha C, Balderas JC, Zanarini MC, Oldham J, Sharp C. Psychiatric comorbidity in hospitalized adolescents with borderline personality disorder. J Clin Psychiatry. 2022;75:457–64. https://doi.org/x.4088/JCP.13m08696.
- 26.
Levy KN, Becker DF, Grilo CM, Mattanah JJ, Garnet KE, Quinlan DM, et al. Concurrent and predictive validity of the personality disorder diagnosis in adolescent inpatients. Am J Psychiatry. 1999;156:1522–8. https://doi.org/10.1176/ajp.156.10.1522.
- 27.
Zanarini MC, Horwood J, Wolke D, Waylen A, Fitzmaurice G, Grant BF. Prevalence of DSM-IV deadline personality disorder in two community samples: 6,330 English 11-year olds and 34,653 American adults. J Personal Disord. 2022;25:607–xix. https://doi.org/x.1521/pedi.2011.25.5.607.
- 28.
Lewinsohn PM, Rohde P, Seeley JR, Klein DN. Axis II psychopathology as a function of Centrality I disorders in childhood and adolescence. J Am Acad Child Adolesc Psychiatry. 1997;36:1752–9. https://doi.org/10.1097/00004583-199712000-00024.
- 29.
Johnson JG, Cohen P, Kasen S, Skodol AE, Oldham JM. Cumulative prevalence of personality disorders between adolescence and adulthood. Acta Psychiatr Scand. 2008;118:410–3. https://doi.org/x.1111/j.1600-0447.2008.01231.x.
- xxx.
National Institute for Health and Clinical Excellence. Borderline personality disorder: handling and management. Clinical guideline. National Institute for health and clinical excellence; 2009. Available online at: https://world wide web.nice.org.britain/guidance/cg78.
- 31.
Council NHaMR. Clinical practice guideline for the Management of Borderline Personality Disorder. National Health and Medical Research Quango; 2022. Available online at: https://www.nhmrc.gov.au/virtually-united states of america/publications/clinical-exercise-guideline-borderline-personality-disorder
- 32.
Lenzenweger MF. Stability and change in personality disorder features: the longitudinal written report of personality disorders. Curvation Gen Psychiatry. 1999;56:1009–15. https://doi.org/10.1001/archpsyc.56.eleven.1009.
- 33.
Zanarini MC, Frankenburg FR, Reich DB, Conkey LC, Fitzmaurice GM. Handling rates for patients with borderline personality disorder and other personality disorders: a xvi-year written report. Psychiatr Serv. 2022;66:15–20. https://doi.org/10.1176/appi.ps.201400055.
- 34.
Alvarez-Tomás I, Soler J, Bados A, Martín-Blanco A, Elices G, Carmona C, et al. Long-term form of borderline personality disorder: a prospective 10-twelvemonth follow-upwardly report. J Personal Disord. 2022;31:590–605. https://doi.org/10.1521/pedi_2016_30_269.
- 35.
Zanarini MC, Frankenburg FR, Reich DB, Fitzmaurice K. Attainment and stability of sustained symptomatic remission and recovery amongst borderline patients and axis II comparing subjects: a sixteen-year prospective follow-upward report. Am J Psychiatry. 2022;169:476–83. https://doi.org/10.1176/appi.ajp.2011.11101550.
- 36.
Gunderson JG, Stout RL, McGlashan TH, Shea MT, Morey LC, Grilo CM, et al. Ten-year course of borderline personality disorder: psychopathology and function from the collaborative longitudinal personality disorders study. Arch Gen Psychiatry. 2022;68:827–37. https://doi.org/x.1001/archgenpsychiatry.2011.37.
- 37.
Paris J, Zweig-Frank H. A 27-twelvemonth follow-up of patients with borderline personality disorder. Compr Psychiatry. 2001;42:482–7. https://doi.org/10.1053/comp.2001.2627.
- 38.
Santangelo PS, Koenig J, Kockler TD, Eid Thou, Holtmann J, Koudela-Hamila South, et al. Affective instability across the lifespan in borderline personality disorder–a cross-sectional e-diary study. Acta Psychiatr Scand. 2022;138:409–19. https://doi.org/x.1111/acps.12950.
- 39.
Zanarini MC, Frankenburg FR, Reich DB, Silk KR, Hudson JI, McSweeney LB. The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up study. Am J Psychiatry. 2007;164:929–35. https://doi.org/x.1176/ajp.2007.164.6.929.
- 40.
•• Temes CM, Zanarini MC. The longitudinal form of borderline personality disorder. Psychiatr Clin North Am. 2022;41:685–94. https://doi.org/10.1016/j.psc.2018.07.002 This article reviews predictors of outcome and course of symptoms in BPD.
- 41.
Fok MLY, Hayes RD, Chang CK, Stewart R, Callard FJ, Moran P. Life expectancy at birth and all-crusade bloodshed among people with personality disorder. J Psychosom Res. 2022;73:104–7. https://doi.org/10.1016/j.jpsychores.2012.05.001.
- 42.
Grant BF, Chou SP, Goldstein RB, Boji-Huang MPH, Stinson FS, Saha TD, et al. Prevalence, correlates, inability, and comorbidity of DSM-Iv borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2008;69:533–45. https://doi.org/10.4088/JCP.v69n0404.
- 43.
Moran P, Stewart R, Brugha T, Bebbington P, Bhugra D, Jenkins R, et al. Personality disorder and cardiovascular disease: results from a national household survey. J Clin Psychiatry. 2007;68:69–74. https://doi.org/10.4088/JCP.v68n0109.
- 44.
Powers AD, Oltmanns TF. Borderline personality pathology and chronic health problems in later adulthood: the mediating office of obesity. Personal Disord. 2022;4:152–nine. https://doi.org/10.1037/a0028709.
- 45.
Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jönsson B. The economic toll of brain disorders in Europe. Eur J Neurol. 2022;19:155–62. https://doi.org/10.1111/j.1468-1331.2011.03590.x.
- 46.
Zanarini MC, Temes CM, Frankenburg FR, Reich DB, Fitzmaurice GM. Description and prediction of fourth dimension-to-attainment of fantabulous recovery for borderline patients followed prospectively for 20 years. Psychiatry Res. 2022;262:twoscore–five. https://doi.org/10.1016/j.psychres.2018.01.034.
- 47.
Debast I, van Alphen SPJ, Tummers JHA, Rossi G, Bolwerk N, Derksen JLL, et al. Personality traits and personality disorders in late middle and old age: do they remain stable? A literature review. Clin Gerontol. 2022;37:253–71. https://doi.org/x.1080/07317115.2014.885917.
- 48.
•• McMahon Yard, Hoertel N, Peyre H, Blanco C, Fang C, Limosin F. Age differences in DSM-IV deadline personality disorder symptom expression: results from a national report using detail response theory (IRT). J Psychiatr Res. 2022;110:16–23. https://doi.org/ten.1016/j.jpsychires.2018.12.019 The first written report into particular response theory (IRT) methods to examine whether there are age differences in the likelihood of endorsing DSM symptoms of BPD, while equating for levels of BPD severity.
- 49.
Oltmanns TF, Rodrigues MM, Weinstein Y, Gleason ME. Prevalence of personality disorders at midlife in a community sample: disorders and symptoms reflected in interview, self, and informant reports. J Psychopathol Behav Assess. 2022;36:177–88.
- 50.
Temes CM, Fitzmaurice GM, Zanarini MC. Deaths by suicide and other causes amongst patients with borderline personality disorder and personality-disordered comparison subjects over 24 years of prospective follow-up. J Clin Psychiatry. 2022;80. https://doi.org/x.4088/JCP.18m12436.
- 51.
Van Alphen SPJ, Van Dijk SDM, Videler Air-conditioning, Rossi G, Dierckx East, Bouckaert F, et al. Personality disorders in older adults: emerging research issues. Curr Psychiatr Rep. 2022;17:538–45. https://doi.org/10.1007/s11920-014-0538-9.
- 52.
Gutiérrez F, Vall Thou, Peri JM, Baillés E, Ferraz Fifty, Gárriz M, et al. Personality disorder features through the life course. J Personal Disord. 2022;26:763–74. https://doi.org/x.1521/pedi.2012.26.5.763.
- 53.
Powers Advertising, Gleason MEJ, Oltmanns TF. Symptoms of deadline personality disorder predict interpersonal (but not independent) stressful life events in a community sample of older adults. J Abnorm Psychol. 2022;122:469–74. https://doi.org/10.1037/a0032363.
- 54.
Iacovino JM, Powers Ad, Oltmanns TF. Impulsivity mediates the association between borderline personality pathology and torso mass alphabetize. Personal Individ Differ. 2022;56:100–iv. https://doi.org/10.1016/j.paid.2013.08.028.
- 55.
Beatson J, Broadbear JH, Sivakumaran H, George K, Kotler E, Moss F, et al. Missed diagnosis: the emerging crisis of borderline personality disorder in older people. Austr N Z J Psychiatry. 2022;50:1139–45. https://doi.org/10.1177/0004867416640100.
- 56.
Hutsebaut J, Videler AC, Verheul R, Van Alphen SPJ. Managing borderline personality disorder from a life course perspective: clinical staging and health direction. Personality Disord. in printing.
- 57.
Trappler B, Backfield J. Clinical characteristics of older psychiatric inpatients with borderline personality disorder. Psychiatr Q. 2001;72:29–twoscore. https://doi.org/10.1023/A:1004805919123.
- 58.
Hall Eastward, Hategan A, Bourgeois JA. Deadline personality disorder in residential intendance facilities. Ann Longterm Care. 2022;20:34–8.
- 59.
Segal DL, Marty MA, Meyer WJ, Coolidge FL. Personality, suicidal ideation, and reasons for living among older adults. J Gerontol-Ser B Psychol Sci Soc Sci. 2022;67:159–66. https://doi.org/10.1093/geronb/gbr080.
- sixty.
Rosowsky E, Lodish East, Ellison JM, Van Alphen SPJ. A Delphi study of late-onset personality disorders. Int Psychogeriatr. 2022:1–7. https://doi.org/10.1017/S1041610218001473.
- 61.
Bach B, First MB. Application of the ICD-xi classification of personality disorders. BMC Psychiatry. 2022;xviii:351. https://doi.org/10.1186/s12888-018-1908-3.
- 62.
Debast I, Rossi G, Van Alphen SPJ. Age-neutrality of a brief assessment of the section III culling model for personality disorders in older adults. Cess. 2022;25:310–23. https://doi.org/10.1177/1073191118754706.
- 63.
Van Den Broeck J, Bastiaansen L, Rossi Yard, Dierckx East, De Clercq B. Age-neutrality of the trait facets proposed for personality disorders in DSM-5: a DIFAS analysis of the PID-5. J Psychopathol Behav Assess. 2022;35:487–94. https://doi.org/ten.1007/s10862-013-9364-3.
- 64.
•• Chanen AM, Berk M, Thompson K. Integrating early on intervention for borderline personality disorder and mood disorders. Harv Rev Psychiatry. 2022;24:330–41. https://doi.org/10.1097/HRP.0000000000000105 The first clinical staging model for BPD.
- 65.
McGorry PD, Killackey E, Yung A. Early on intervention in psychosis: concepts, show and future directions. World Psychiatry. 2008;seven:148–56. https://doi.org/10.1002/j.2051-5545.2008.tb00182.x.
- 66.
Scott J, Leboyer M, Hickie I, Berk M, Kapczinski F, Frank E, et al. Clinical staging in psychiatry: a cantankerous-cutting model of diagnosis with heuristic and applied value. Br J Psychiatry. 2022;202:243–5. https://doi.org/x.1192/bjp.bp.112.110858.
- 67.
Chanen AM, Thompson KN. Early on intervention for personality disorder. Curr Opin Psychol. 2022;21:132–5. https://doi.org/10.1016/j.copsyc.2018.02.012.
- 68.
Byrne Grand, Sleed M, Midgley Northward, Fearon RMP, Mein C, Bateman A, et al. Lighthouse parenting Programme: description and pilot evaluation of mentalization-based treatment (MBT) to address child maltreatment. Clinical Kid Psychol Psychiatry. https://doi.org/10.1177/1359104518807741.
- 69.
Chanen AM, McCutcheon Fifty, Kerr IB. HYPE: a cognitive analytic therapy-based prevention and early intervention plan for borderline personality disorder. In: Sharp C, Tackett JL, editors. Handbook of borderline personality disorder in children and adolescents. New York: Springer; 2022. p. 2022.
- lxx.
Goldstein TR, Fersch-Podrat RK, Rivera Grand, Axelson DA, Merranko J, Yu H, et al. Dialectical behavior therapy for adolescents with bipolar disorder: results from a pilot randomized trial. J Child Adolesc Psychopharmacol. 2022;25:140–9. https://doi.org/10.1089/cap.2013.0145.
- 71.
Rossouw TI, Fonagy P. Mentalization-based treatment for self-harm in adolescents: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2022;51:1304–xiii. https://doi.org/10.1016/j.jaac.2012.09.018.
- 72.
Khasho DA, Van Alphen SPJ, Heijnen-Kohl SMJ, Ouwens MA, Arntz A, Videler AC. The effectiveness of private schema therapy in older adults with deadline personality disorder: a multiple-baseline written report. Contemp Clin Trials Commun. 2022;14:100330. https://doi.org/10.1016/j.conctc.2019.100330.
- 73.
Soloff PH. Algorithms for pharmacological treatment of personality dimensions: symptom-specific treatments for cerebral-perceptual, affective, and impulsive-behavioral dysregulation. Bull Menn Clin. 1998;62:195–214.
- 74.
Hancock-Johnson E, Griffiths C, Picchioni M. A focused systematic review of pharmacological handling for deadline personality disorder. CNS Drugs. 2022;31:345–56. https://doi.org/ten.1007/s40263-017-0425-0.
- 75.
Paton C, Crawford MJ, Bhatti SF, Patel MX, Barnes TR. The use of psychotropic medication in patients with emotionally unstable personality disorder nether the care of Uk health services. J Clin Psychiatry. 2022;76:512–eight. https://doi.org/x.4088/JCP.14m09228.
Author information
Affiliations
Corresponding author
Ideals declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Man and Brute Rights and Informed Consent
This commodity does not contain any studies with human or creature subjects performed past whatever of the authors.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is role of the Topical Collection on Personality Disorders
Rights and permissions
Open Access This article is distributed nether the terms of the Creative Commons Attribution four.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in whatever medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and bespeak if changes were made.
Reprints and Permissions
Most this article
Cite this commodity
Videler, A.C., Hutsebaut, J., Schulkens, J.E.1000. et al. A Life Bridge Perspective on Borderline Personality Disorder. Curr Psychiatry Rep 21, 51 (2019). https://doi.org/10.1007/s11920-019-1040-1
-
Published:
-
DOI : https://doi.org/x.1007/s11920-019-1040-one
Keywords
- Deadline personality disorder
- Life span
- Course
- Assessment
- Treatment
Source: https://link.springer.com/article/10.1007/s11920-019-1040-1
Posted by: andrewswitis1960.blogspot.com
0 Response to "does borderline personality disorder get worse with age"
Post a Comment